Fundai

Caspian Tamin Pharmaceutical Company (KASPIAN) income statement

Operating revenue through to net profit and earnings per share

Ticker
KASPIAN
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue68,122,65121,959,59710,994,1658,095,6925,873,9364,079,113
Cost of operating revenue-16,158,778-7,379,782-5,656,529-4,443,500-3,131,695-2,074,718
Gross profit (loss)51,963,87314,579,8155,337,6363,652,1922,742,2412,004,395
Selling, general and administrative expenses-901,475-354,442-276,957-189,464-146,700-112,178
Other income70,28619,12669,74623,07716,19619,336
Other expenses-4,397-14,957-13,831-26,474-3,048-693
Operating profit (loss)51,128,28714,229,5425,116,5943,459,3312,608,6891,910,860
Finance costs-3,193,155-1,908,872-1,116,009-706,460-627,144-471,960
Other non-operating income and expenses208,03526,96830,7067,6819,0556,420
Profit (loss) from continuing operations before tax48,143,16712,347,6384,031,2912,760,5521,990,6001,445,320
Current year tax-11,380,958-2,912,784-930,418-607,794-408,957-286,966
Net profit (loss) from continuing operations36,762,2099,434,8543,100,8732,152,7581,581,6431,158,354
Net profit (loss)36,762,2099,434,8543,100,8732,152,7581,581,6431,158,354
Basic earnings (loss) per share4,644 rials1,189 rials2,223 rials1,549 rials2,266 rials1,662 rials
Net earnings (loss) per share, rials4,631 rials1,189 rials2,215 rials1,538 rials2,260 rials1,655 rials
Capital7,940,0007,940,0001,400,0001,400,000700,000700,000

Reporting periods

58 periods are on file for this report, from the period ending 1392/12/29 to the period ending 1405/06/31.